Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage (Q46656102)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1999

Language	Label	Description	Also known as
English	Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage	scientific article published in February 1999

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

blood–brain barrier

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

author name string

Su GC

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Arendash GW

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Kalaria RN

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Bjugstad KB

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

818

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

105-117

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Patterns of gliosis in Alzheimer's disease and aging cerebrum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Brain microvascular changes in Alzheimer's disease and other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Platelets are the primary source of amyloid beta-peptide in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Perivascular astrocytes within Alzheimer's disease plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Alzheimer amyloid beta-peptides exhibit ionophore-like properties in human erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

The alveolar macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-protein (A beta) accumulation in the leptomeninges during aging and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Differences between vascular and plaque core amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebrovascular endothelial dysfunction mediated by beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901143-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(98)01143-3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/9914443

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46656102&oldid=2124977527"